echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Professor Liu Yanying: How to do a good job in the treatment and management of rheumatoid arthritis?

    Professor Liu Yanying: How to do a good job in the treatment and management of rheumatoid arthritis?

    • Last Update: 2022-08-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    *For medical professional reading reference only

    "Because it is needed, it pays more attention



    In 2021, 43-year-old Liu Yanying made an important life choice


    On the new platform, Liu Yanying



    Professor Liu Yanying emphasized that the early diagnosis of RA has a great impact on treatment and prognosis [ 1]



    RA is a chronic systemic inflammatory disease that requires lifelong treatment



    According to statistics, more than 60% of RA patients in China have missed or voluntarily reduced or stopped taking drugs



    Professor Liu Yanying believes that good daily management of RA patients should include: diet, proper living, correct medication, protection and restoration of joint function, functional exercise strategies, common symptom care, avoidance of disease triggers, self-monitoring and regular review and consultation



    It has been 7 months since I was in charge of the rheumatology department in Friendship Hospital


    Informed consent has been obtained for the photo Liu Yanying Chief Physician, Professor, Doctoral/Postdoctoral Supervisor


    [2] Wang Tao, Li Zhijun.


    [3] He Guoxia, Tan Wenfeng, Zhou Lanlan, Zhu Xiaoqian, Ding Yu.
    Application effect of self-management model in patients with rheumatoid arthritis [J].
    Journal of Practical Clinical Medicine, 2018, 22(06): 54-56.

    [4] Liu Yi.
    "Value-oriented" management of chronic rheumatism [J].
    China Medical Information Herald, 2018, 33(11):1.

    [5] Catriona Grigor, et al.
    Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial.

    PP-BA-CN-1767

    This article is only used to provide scientific information to healthcare professionals and does not represent the platform's position
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.